ARTICLE https://harbor-dev.pubfactory.com/view/journals/jnccn/10/1/article-pxiv.xml NCCN News 2019-01-02 https://harbor-dev.pubfactory.com/view/journals/jnccn/10/1/article-pxxvii.xml Oncology Research Program 2019-01-02 https://harbor-dev.pubfactory.com/view/journals/jnccn/10/1/article-p1.xml Correspondence 2019-01-02 https://harbor-dev.pubfactory.com/view/journals/jnccn/10/1/article-p3.xml JNCCN Reaches 10 2019-01-02 https://harbor-dev.pubfactory.com/view/journals/jnccn/10/1/article-p4.xml JNCCN at 10 2019-01-02 https://harbor-dev.pubfactory.com/view/journals/jnccn/10/1/article-p7.xml By the Pricking of My Thumbs, Something Wicked This Way Comes: Sporadic Cancers Versus Eponymous Hereditary Cancer Predisposition Syndromes 2019-01-02 https://harbor-dev.pubfactory.com/view/journals/jnccn/10/1/article-p18.xml Value-Based Insurance Design: Aligning Incentives, Benefits, and Evidence in Oncology 2019-01-02 https://harbor-dev.pubfactory.com/view/journals/jnccn/10/1/article-p26.xml Malignant Pleural Mesothelioma 2019-01-02 https://harbor-dev.pubfactory.com/view/journals/jnccn/10/1/article-p42.xml Novel Therapies in Phase II and III Trials for Malignant Pleural Mesothelioma 2019-01-02 https://harbor-dev.pubfactory.com/view/journals/jnccn/10/1/article-p49.xml Current Concepts in the Evaluation and Treatment of Patients With Diffuse Malignant Peritoneal Mesothelioma 2019-01-02 https://harbor-dev.pubfactory.com/view/journals/jnccn/10/1/article-p64.xml Chronic Myelogenous Leukemia 2019-01-02 https://harbor-dev.pubfactory.com/view/journals/jnccn/10/1/article-p112.xml How to Choose Frontline Therapy for Chronic Myelogenous Leukemia: So Many Drugs, Not So Many Patients 2019-01-02 https://harbor-dev.pubfactory.com/view/journals/jnccn/10/1/article-p121.xml Practical Monitoring of Chronic Myelogenous Leukemia: When to Change Treatment 2019-01-02 https://harbor-dev.pubfactory.com/view/journals/jnccn/10/1/article-p130.xml Health Care Reform and Its Implications for the Academic Cancer Center 2019-01-02